Molecular diagnostics startup Proteocyte Diagnostics joins MaRS SVX
Proteocyte Diagnostics Inc, developer of a novel diagnostics test for early identification of oral cancers, has joined crowdfunding platform MaRS Social Venture Connexion (SVX). Founded in 2011, Proteocyte Diagnostics is based in Toronto. MaRS SVX was launched last year to link accredited investors with profitable companies that make a social or environmental impact. There are currently 20 public share issuers on the platform, which is sponsored by Canadian innovation hub MaRS Discovery District. Issuers have raised a combined $1.2 million in funding to date.
15 July 2014•3 mins read
